Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 19 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52
Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 19 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52
HITLAB is pleased to announce that Olivier Rabenschlag, former Google executive and Founding Partner of Chapter 3 Captial, has joined the Breakthrough Alliance (BTA) board. Chapter 3 Capital offers a unique blend of human and financial resources to early stage startups including those in AI, Big Data and Blockchain; Healthcare and Climate-tech ventures; and Social Enterprises.
Prior to founding Chapter 3 Capital, Olivier spent 11 years at Google, where he built, humanized and commercialized a myriad of emerging technologies from the ground up and scaling them to the masses. He was also an investor across 20 companies including 4 unicorns and 1 decacorn. Olivier started his career in the advertising industry, where he successfully built-up brands using his creativity and marketing skills.
“We are excited to expand our BTA board with the addition of Olivier Rabenschlag,” said Bill Taranto, CEO of Merck Global health Innovation Fund and Chair of HITLAB BTA. “With his 25-years of experience, Olivier brings with him a unique and diverse expertise set of skills that can help with our mission to improve the delivery of healthcare. We have worked hard to ensure that our BTA board represents a variety of experts from the healthcare world. We welcome Olivier to the team.”
The BTA is a digital health consortium of executive leaders from across life science, pharmaceutical, academic medical institutions, and healthcare providers, including New York City Economic Development Corporation, Merck Global Health Innovation, Johnson & Johnson, Medidata, Fund LLC, BDO, Atlas Venture, StartUp Health, CATALAIZE, Consummate Capital, EdgeOne Medical, Esplanade Ventures, FFF Enterprises and Northwell Health, all committed to improving health outcomes and care delivery through verified emerging technologies. The board is chaired by Bill Taranto, the CEO of the Merck Global Innovation Fund.
The BTA board meets every quarter. All members have the benefits of:
- Setting priorities to guide the development of research studies for selected digital health technologies
- Receiving exclusive access to investment and partnership opportunities with the latest digital health tech under development
- Gaining insights into the future of digital health by seeing the results of the verified and risk-reduced studies.
“The mission of HITLAB’s BTA resonates deeply with the work I have done throughout the last 25 years,” said Oliver Rabenschlag, Founding Partner of Chapter 3 Capital. “I look forward to helping founders access the financial and human capital they need to succeed.”
ABOUT HITLAB
Established in 1998, HITLAB is a leading evidence-based, healthcare innovation lab specializing in the delivery of world-class digital health research and education. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges across the globe. HITLAB works with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.
About HITLAB Breakthrough Alliance
HITLAB Breakthrough Alliance is an accelerator that helps early-stage startups conduct rapid pilot studies to test their products and move closer to market. Selected startups have their technologies tested in pilot studies with clinical partners and patients, gathering the data needed to accelerate their concepts. To source startups, Breakthrough holds open innovation competitions and networking events that bring together the digital health and investment ecosystem.
Breakthrough is membership-based and board members represent the best organizations in healthcare.
